Category Archives: Healthcare

Incyte Corp Gets a Buy Rating from J.P. Morgan

In a report issued on June 21, Cory Kasimov from J.P. Morgan assigned a Buy rating to Incyte Corp (NASDAQ: INCY), with a price target of $88. The company’s shares closed on Friday at $74.03. Kasimov said: “We came away

Synergy Pharmaceuticals Inc Receives a Hold from Cantor Fitzgerald

Cantor Fitzgerald analyst William Tanner maintained a Hold rating on Synergy Pharmaceuticals Inc (NASDAQ: SGYP) yesterday. The company’s shares closed on Friday at $1.89, close to its 52-week low of $1.43. According to TipRanks.com, Tanner is a 4-star analyst with

A Director at Xenon is Exercising Options

Today, a Director at Xenon, Mohammad Azab, exercised options of Xenon (NASDAQ: XENE) for $38.07K. The options were close to expired and Mohammad Azab retained stocks. This recent transaction increases Mohammad Azab’s holding in the company by 23.27% to a

Friday’s Midday Movers: Rosetta Genomics Ltd (ROSG), Orexigen (OREX), Cytori Therapeutics Inc (CYTX), Civeo Corp (CVEO), BlackBerry Limited (BB)

So far Friday, June 22, NASDAQ is down -1.4% and the S&P is down -0.26%. Here are this morning’s most active stocks: Rosetta Genomics Ltd (NASDAQ:ROSG), Orexigen (NASDAQ:OREX), Cytori Therapeutics Inc (NASDAQ:CYTX), Civeo Corp (NYSE:CVEO) and BlackBerry Limited (NYSE:BB). Rosetta

TD Securities Downgrades Valeant Pharma to Hold

In a report released today, Lennox Gibbs from TD Securities downgraded Valeant Pharma (NYSE: VRX) to Hold. The company’s shares closed yesterday at $24.72. According to TipRanks.com, Gibbs is ranked #4591 out of 4829 analysts. Currently, the analyst consensus on

Mizuho Securities Sticks to Their Buy Rating for Amgen Inc

Mizuho Securities analyst Salim Syed maintained a Buy rating on Amgen Inc (NASDAQ: AMGN) today and set a price target of $200. The company’s shares closed yesterday at $185.99. According to TipRanks.com, Syed is a 2-star analyst with an average